Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Mouse Serpin I1 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB3124
This item is not returnable.
View return policy
Description
Serpin I1/Neuroserpin Monoclonal specifically detects Serpin I1/Neuroserpin in Human, Mouse samples. It is validated for Western Blot.Specifications
Serpin I1/Neuroserpin | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL | |
AAH18043 | |
SERPINI1 | |
Mouse myeloma cell line NS0-derived recombinant human Serpin I1 Ala19-Leu410 Accession # AAH18043 | |
100 μg | |
Primary | |
Detects human and mouse SerpinI1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, 100% cross reactivity with recombinant mouse Serpin I1 is observed and no cross-reactivity with recombinant human Serpin A1, A3, A4, A5, A12, B6, B8, B9, C1, D1, F2, G1, or I2 is observed. | |
Human, Mouse | |
Purified |
Western Blot | |
437016 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
DKFZp781N13156, Neuroserpin, Peptidase inhibitor 12, PI12, PI-12, PI12Serpin I1, serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), member 1, serpin peptidase inhibitor, clade I (neuroserpin), member 1 | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
5274 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction